CSIMarket
 


Odonate Therapeutics Inc   (ODT)
Other Ticker:  
 

Cumulative Odonate Therapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

ODT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ODT Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Equity Growth -56.9 % -19.82 % -22.14 % -16.12 % -11.06 %
Y / Y Total Liabilities Growth 3.03 % 24.91 % 40.53 % 19.66 % 17.56 %
Leverage Ratio for Trailing Twelve Months Period 0.35 0.28 0.25 0.22 0.2
Total Ranking # 844 # 647 # 582 # 452 # 372
Seq. Equity Growth -15.66 % -19.64 % -22.66 % -17.79 % 56.9 %
Seq. Total Liabilities Growth 1.34 % -9.66 % 18.39 % -4.94 % 22.86 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2021
On the trailing twelve months basis Due to net new borrowings of 1.34%, Leverage Ratio for Trailing Twelve Months Period improved to 0.35, below Odonate Therapeutics Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 266 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Odonate Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are ODT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 267
Sector # 473
S&P 500 # 1061


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
5.66 0.59 0.08
(Dec 31 2016)   (Mar 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2021, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Unity Biotechnology Inc   0.95 
Mirum Pharmaceuticals Inc   0.95 
Point Biopharma Global Inc   0.93 
Merus N v   0.93 
Affimed N v   0.93 
Aveo Pharmaceuticals Inc   0.92 
Cumberland Pharmaceuticals Inc  0.92 
Corbus Pharmaceuticals Holdings Inc   0.91 
Kineta Inc   0.91 
Innoviva Inc   0.91 
Abbott Laboratories  0.90 
Heron Therapeutics Inc   0.89 
Reata Pharmaceuticals Inc   0.89 
Vyne Therapeutics Inc   0.89 
Tango Therapeutics Inc   0.88 
Zogenix Inc   0.88 
Trevi Therapeutics Inc   0.88 
Aditxt Inc   0.87 
Minerva Neurosciences Inc   0.86 
Axsome Therapeutics Inc   0.86 
Contrafect Corporation  0.85 
Beyondspring Inc   0.85 
Chiasma Inc   0.84 
Seres Therapeutics Inc   0.82 
4d Pharma Plc  0.81 
Sanofi  0.81 
Supernus Pharmaceuticals inc   0.81 
Urogen Pharma Ltd   0.80 
Gossamer Bio Inc   0.79 
Jazz Pharmaceuticals Plc  0.79 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com